Publication Information

{'id': 'https://openalex.org/W4392843431', 'doi': 'https://doi.org/10.1136/bmjno-2023-anzan.131', 'title': '2757 Case report: focal seizure secondary to immune checkpoint inhibitor-induced autoimmune encephalitis', 'display_name': '2757 Case report: focal seizure secondary to immune checkpoint inhibitor-induced autoimmune encephalitis', 'publication_year': 2023, 'publication_date': '2023-08-01', 'ids': {'openalex': 'https://openalex.org/W4392843431', 'doi': 'https://doi.org/10.1136/bmjno-2023-anzan.131'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/bmjno-2023-anzan.131', 'pdf_url': 'https://neurologyopen.bmj.com/content/bmjno/5/Suppl_1/A47.3.full.pdf', 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'proceedings-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://neurologyopen.bmj.com/content/bmjno/5/Suppl_1/A47.3.full.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100917623', 'display_name': 'Xi Jia', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801688508', 'display_name': 'Nepean Hospital', 'ror': 'https://ror.org/03vb6df93', 'country_code': 'AU', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801688508']}], 'countries': ['AU'], 'is_corresponding': False, 'raw_author_name': 'Xi (Jessica) Jia', 'raw_affiliation_strings': ['Nepean Hospital, Kingswood, NSW, Australia'], 'affiliations': [{'raw_affiliation_string': 'Nepean Hospital, Kingswood, NSW, Australia', 'institution_ids': ['https://openalex.org/I2801688508']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024796715', 'display_name': 'Manori Wijayath', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801688508', 'display_name': 'Nepean Hospital', 'ror': 'https://ror.org/03vb6df93', 'country_code': 'AU', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801688508']}], 'countries': ['AU'], 'is_corresponding': False, 'raw_author_name': 'Manori Wijayath', 'raw_affiliation_strings': ['Nepean Hospital, Kingswood, NSW, Australia'], 'affiliations': [{'raw_affiliation_string': 'Nepean Hospital, Kingswood, NSW, Australia', 'institution_ids': ['https://openalex.org/I2801688508']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5103176672', 'display_name': 'Hyunmin Park', 'orcid': 'https://orcid.org/0000-0002-8284-9504'}, 'institutions': [{'id': 'https://openalex.org/I2801688508', 'display_name': 'Nepean Hospital', 'ror': 'https://ror.org/03vb6df93', 'country_code': 'AU', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801688508']}], 'countries': ['AU'], 'is_corresponding': False, 'raw_author_name': 'Hyunmin Park', 'raw_affiliation_strings': ['Nepean Hospital, Kingswood, NSW, Australia'], 'affiliations': [{'raw_affiliation_string': 'Nepean Hospital, Kingswood, NSW, Australia', 'institution_ids': ['https://openalex.org/I2801688508']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.396, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.598845, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 68, 'max': 79}, 'biblio': {'volume': None, 'issue': None, 'first_page': 'A47.3', 'last_page': 'A48'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13201', 'display_name': 'Infectious Encephalopathies and Encephalitis', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13201', 'display_name': 'Infectious Encephalopathies and Encephalitis', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11368', 'display_name': 'Long-Term Effects of COVID-19', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11627', 'display_name': 'Autoimmune Neurological Disorders and Treatments', 'score': 0.9974, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/levetiracetam', 'display_name': 'Levetiracetam', 'score': 0.54050016}, {'id': 'https://openalex.org/keywords/autoimmune-encephalitis', 'display_name': 'Autoimmune encephalitis', 'score': 0.5161987}, {'id': 'https://openalex.org/keywords/prednisolone', 'display_name': 'Prednisolone', 'score': 0.50197005}, {'id': 'https://openalex.org/keywords/limbic-encephalitis', 'display_name': 'Limbic Encephalitis', 'score': 0.48162097}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8633957}, {'id': 'https://openalex.org/C2777332695', 'wikidata': 'https://www.wikidata.org/wiki/Q417227', 'display_name': 'Levetiracetam', 'level': 3, 'score': 0.54050016}, {'id': 'https://openalex.org/C2781460105', 'wikidata': 'https://www.wikidata.org/wiki/Q16918461', 'display_name': 'Autoimmune encephalitis', 'level': 4, 'score': 0.5161987}, {'id': 'https://openalex.org/C2776715498', 'wikidata': 'https://www.wikidata.org/wiki/Q11426176', 'display_name': 'Prednisolone', 'level': 2, 'score': 0.50197005}, {'id': 'https://openalex.org/C2777699746', 'wikidata': 'https://www.wikidata.org/wiki/Q282783', 'display_name': 'Limbic encephalitis', 'level': 4, 'score': 0.48162097}, {'id': 'https://openalex.org/C146638467', 'wikidata': 'https://www.wikidata.org/wiki/Q10529587', 'display_name': 'Hyperintensity', 'level': 3, 'score': 0.43447044}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33399266}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3240192}, {'id': 'https://openalex.org/C2778186239', 'wikidata': 'https://www.wikidata.org/wiki/Q41571', 'display_name': 'Epilepsy', 'level': 2, 'score': 0.29819334}, {'id': 'https://openalex.org/C163764329', 'wikidata': 'https://www.wikidata.org/wiki/Q785022', 'display_name': 'Autoantibody', 'level': 3, 'score': 0.25221258}, {'id': 'https://openalex.org/C143409427', 'wikidata': 'https://www.wikidata.org/wiki/Q161238', 'display_name': 'Magnetic resonance imaging', 'level': 2, 'score': 0.18169755}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.14696193}, {'id': 'https://openalex.org/C126838900', 'wikidata': 'https://www.wikidata.org/wiki/Q77604', 'display_name': 'Radiology', 'level': 1, 'score': 0.111090064}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/bmjno-2023-anzan.131', 'pdf_url': 'https://neurologyopen.bmj.com/content/bmjno/5/Suppl_1/A47.3.full.pdf', 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/bmjno-2023-anzan.131', 'pdf_url': 'https://neurologyopen.bmj.com/content/bmjno/5/Suppl_1/A47.3.full.pdf', 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 5, 'referenced_works': ['https://openalex.org/W2107126732', 'https://openalex.org/W2767385141', 'https://openalex.org/W4205749881', 'https://openalex.org/W4220982527', 'https://openalex.org/W4392843427'], 'related_works': ['https://openalex.org/W4387325080', 'https://openalex.org/W4322012592', 'https://openalex.org/W3213419122', 'https://openalex.org/W3153887325', 'https://openalex.org/W3009907571', 'https://openalex.org/W2987250549', 'https://openalex.org/W2966977603', 'https://openalex.org/W2775574164', 'https://openalex.org/W2770634046', 'https://openalex.org/W2577296490'], 'abstract_inverted_index': {'<h3>Background</h3>': [0], 'Immune': [1], 'checkpoint': [2], 'inhibitors': [3], '(ICI)': [4], 'are': [5], 'a': [6, 71], 'new': [7, 54], 'class': [8], 'of': [9, 21, 41, 45, 56, 73, 83, 144, 176, 189, 197, 208, 223, 235], 'therapy': [10, 147, 237], 'used': [11], 'to': [12, 30, 151, 213, 230, 241], 'treat': [13], 'many': [14], 'advanced': [15, 74], 'malignancies.': [16], 'There': [17], 'is': [18, 39, 69], 'increased': [19], 'recognition': [20], 'rare': [22], 'and': [23, 66, 85, 98, 101, 112, 128, 141, 185, 202], 'severe': [24, 153], 'neurological': [25], 'immune-related': [26], 'adverse': [27], 'events(irAEs)': [28], 'related': [29], 'ICI': [31, 146, 236], 'treatment,': [32], 'such': [33], 'as': [34], 'autoimmune': [35], 'encephalitis': [36, 103], '(AE).': [37], 'Seizure': [38], 'one': [40], 'the': [42, 152, 170, 220], 'common': [43], 'manifestations': [44], 'AE.': [46, 120, 232], '<h3>Case': [47], 'Description</h3>': [48], 'A': [49], '72-year-old': [50], 'man': [51], 'presented': [52], 'with': [53, 63, 80, 87, 119, 124, 132, 174, 183, 187], 'onset': [55], 'refractory': [57], 'focal': [58, 227], 'motor': [59], 'seizures': [60], 'despite': [61], 'treatment': [62], 'levetiracetam,': [64], 'phenytoin': [65], 'clobazam.': [67], 'This': [68, 217], 'on': [70, 138, 194], 'background': [72], 'mesothelioma,': [75], 'which': [76], 'he': [77], 'was': [78, 122, 136, 148, 181, 192], 'treated': [79, 123], '3': [81], 'cycles': [82], 'ipilimumab': [84], 'nivolumab': [86], 'good': [88], 'partial': [89], 'response.': [90, 134], 'CSF': [91], 'studies': [92], 'had': [93, 107, 159, 165], 'shown': [94, 108, 166], 'negative': [95, 99], 'infection': [96], 'screen,': [97], 'anti-neuronal': [100], 'limbic': [102], 'antibodies.': [104], 'MRI': [105, 163], 'Brain': [106, 164], 'multifocal': [109], 'bilateral': [110], 'cortical': [111], 'subcortical': [113], 'FLAIR': [114, 167], 'hyperintensity,': [115], 'most': [116, 177], 'in': [117, 169, 225, 248], 'keeping': [118], 'Patient': [121], 'IV': [125, 129], 'immunoglobulin': [126], '(IVIg)': [127], 'methylprednisolone': [130], '(IVMP)': [131], 'excellent': [133], 'He': [135, 180, 191], 'discharged': [137, 193], 'anti-seizure': [139], 'medications(ASM)': [140], 'tapering': [142], 'dose': [143, 196], 'prednisolone.': [145], 'ceased': [149], 'due': [150], 'irAE.': [154], 'Four': [155], 'months': [156, 205], 'later,': [157], 'patient': [158], 'recurrent': [160], 'seizures.': [161, 190], 'Repeat': [162], 'hyperintensity': [168], 'right': [171], 'occipital/parietal': [172], 'lobes': [173], 'resolution': [175], 'previous': [178], 'lesions.': [179], 're-loaded': [182], 'IVIg': [184], 'IVMP': [186], 'cessation': [188, 207, 234], 'weaning': [195], 'prednisolone,': [198], 'maintenance': [199], 'IVIg,': [200], 'mycophenolate,': [201], 'ASM.': [203], 'Ten': [204], 'after': [206], 'immunotherapy,': [209], "patient's": [210], 'mesothelioma': [211], 'continued': [212], 'be': [214], 'stable.': [215], '<h3>Conclusion</h3>': [216], 'case': [218], 'highlights': [219], 'important': [221], 'role': [222], 'immunotherapy': [224], 'treating': [226], 'seizure': [228], 'secondary': [229], 'ICI-induced': [231], 'Interestingly,': [233], 'did': [238], 'not': [239], 'lead': [240], 'tumor': [242], 'progression': [243], 'at': [244], '1': [245], 'year': [246], 'follow-up': [247], 'this': [249], 'case.': [250]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4392843431', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}], 'updated_date': '2024-12-18T07:08:32.618598', 'created_date': '2024-03-15'}